Regulus Therapeutics Statistics
Total Valuation
TADAWUL:9634 has a market cap or net worth of SAR 525.00 million. The enterprise value is 491.99 million.
Market Cap | 525.00M |
Enterprise Value | 491.99M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | Aug 11, 2025 |
Share Statistics
TADAWUL:9634 has 5.00 million shares outstanding.
Current Share Class | 5.00M |
Shares Outstanding | 5.00M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
The trailing PE ratio is 8.24.
PE Ratio | 8.24 |
Forward PE | n/a |
PS Ratio | 4.34 |
PB Ratio | 5.84 |
P/TBV Ratio | 5.85 |
P/FCF Ratio | 8.98 |
P/OCF Ratio | 8.91 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.86, with an EV/FCF ratio of 8.42.
EV / Earnings | 7.72 |
EV / Sales | 4.06 |
EV / EBITDA | 7.86 |
EV / EBIT | 8.00 |
EV / FCF | 8.42 |
Financial Position
The company has a current ratio of 7.45
Current Ratio | 7.45 |
Quick Ratio | 7.02 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 9,794.31 |
Financial Efficiency
Return on equity (ROE) is 74.28% and return on invested capital (ROIC) is 44.78%.
Return on Equity (ROE) | 74.28% |
Return on Assets (ROA) | 39.20% |
Return on Invested Capital (ROIC) | 44.78% |
Return on Capital Employed (ROCE) | 65.11% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 1.23 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, TADAWUL:9634 has paid 912,190 in taxes.
Income Tax | 912,190 |
Effective Tax Rate | 1.41% |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 62.84 |
Average Volume (20 Days) | 8,759 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TADAWUL:9634 had revenue of SAR 121.04 million and earned 63.69 million in profits. Earnings per share was 12.74.
Revenue | 121.04M |
Gross Profit | 105.42M |
Operating Income | 61.53M |
Pretax Income | 64.60M |
Net Income | 63.69M |
EBITDA | 62.34M |
EBIT | 61.53M |
Earnings Per Share (EPS) | 12.74 |
Balance Sheet
The company has 33.01 million in cash and n/a in debt, giving a net cash position of 33.01 million or 6.60 per share.
Cash & Cash Equivalents | 33.01M |
Total Debt | n/a |
Net Cash | 33.01M |
Net Cash Per Share | 6.60 |
Equity (Book Value) | 89.86M |
Book Value Per Share | 17.97 |
Working Capital | 30.33M |
Cash Flow
In the last 12 months, operating cash flow was 58.90 million and capital expenditures -444,190, giving a free cash flow of 58.45 million.
Operating Cash Flow | 58.90M |
Capital Expenditures | -444,190 |
Free Cash Flow | 58.45M |
FCF Per Share | 11.69 |
Margins
Gross margin is 87.09%, with operating and profit margins of 50.83% and 52.62%.
Gross Margin | 87.09% |
Operating Margin | 50.83% |
Pretax Margin | 53.37% |
Profit Margin | 52.62% |
EBITDA Margin | 51.50% |
EBIT Margin | 50.83% |
FCF Margin | 48.29% |
Dividends & Yields
This stock pays an annual dividend of 3.00, which amounts to a dividend yield of 2.86%.
Dividend Per Share | 3.00 |
Dividend Yield | 2.86% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 62.80% |
Buyback Yield | n/a |
Shareholder Yield | 2.86% |
Earnings Yield | 12.13% |
FCF Yield | 11.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
TADAWUL:9634 has an Altman Z-Score of 4.2 and a Piotroski F-Score of 6.
Altman Z-Score | 4.2 |
Piotroski F-Score | 6 |